All News about Crispr Therapeutics Ag
![](https://g.foolcdn.com/editorial/images/718739/science-lab-research-women-in-stem.jpg)
![](https://investorplace.com/wp-content/uploads/2018/04/biosciences.jpg)
![](https://investorplace.com/wp-content/uploads/2023/02/buy-or-sell1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/02/01/edit_logo_light__796db60d07928674d783a74bde03fba4.png?width=1200&height=800&fit=crop)
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
February 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/01/jim_cramer_shutterstock2.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/718273/investor-looks-at-phone-in-cafe-while-drinking-espresso.jpg)
![](https://g.foolcdn.com/editorial/images/716825/gettyimages-468679176.jpg)
![](https://g.foolcdn.com/editorial/images/716303/gettyimages-1292931102.jpg)
Expert Ratings for CRISPR Therapeutics
January 05, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://g.foolcdn.com/editorial/images/717792/young-patient-in-hospital-bed.jpg)
![](https://investorplace.com/wp-content/uploads/2019/12/gene-editing.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_a_1600.jpg)
![](https://g.foolcdn.com/editorial/images/716946/moonlake.jpg)
![](https://g.foolcdn.com/editorial/images/717183/light-bulb-question-marks-woman.jpg)
![](https://g.foolcdn.com/editorial/images/716744/a-person-removing-a-segment-from-dna.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://g.foolcdn.com/editorial/images/716634/gettyimages-457207669.jpg)
![](https://g.foolcdn.com/editorial/images/716200/gettyimages-1335027284.jpg)
![](https://g.foolcdn.com/editorial/images/714588/stethoscope-on-money-cash.jpg)
![](https://g.foolcdn.com/editorial/images/715706/an-excited-investor-looking-at-a-chart.jpg)
![](https://g.foolcdn.com/editorial/images/715968/gettyimages-1203044156.jpg)
![](https://g.foolcdn.com/editorial/images/715732/young_woman_trading_online.jpg)
![](https://g.foolcdn.com/editorial/images/715162/investor-talks-with-group-of-medical-professionals.jpg)
![](https://g.foolcdn.com/editorial/images/714998/patient-sitting-on-hospital-bed.jpg)
![](https://www.investors.com/wp-content/uploads/2019/01/stock-gene-03-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/04/shutterstock_1179311608.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/715089/gettyimages-869647868.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.